Verifiable by Construction: Claim-Level Evaluation of Verbatim Citation in Clinical Question Answering
Paper • 2609.15964 • Published
question_id stringlengths 33 41 | question stringlengths 87 312 | question_style stringclasses 3
values | guideline_id stringclasses 4
values | guideline_name stringclasses 4
values | source dict |
|---|---|---|---|---|---|
blood-pressure-2025_sec-10-1_lookup_q01 | What is recommended for adults with hypertension to minimize the risk of orthostatic hypotension? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-1"
],
"title_path": [
"Complications of Management",
"Management of OH"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-1",
"char_count": 6160
} |
blood-pressure-2025_sec-10-1_scenario_q01 | A 72-year-old man is on intensive blood pressure-lowering therapy but reports no symptoms of dizziness or fainting. What is the guideline's recommendation regarding his treatment goals for blood pressure? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-1"
],
"title_path": [
"Complications of Management",
"Management of OH"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-1",
"char_count": 6160
} |
blood-pressure-2025_sec-10-1_sdm_q01 | How can I effectively communicate to my patient the importance of monitoring for orthostatic hypotension when initiating or intensifying their antihypertensive treatment? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-1"
],
"title_path": [
"Complications of Management",
"Management of OH"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-1",
"char_count": 6160
} |
blood-pressure-2025_sec-10-2_lookup_q01 | What is the recommended management for adults experiencing a hypertensive emergency with evidence of acute target organ damage? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-2"
],
"title_path": [
"Complications of Management",
"Hypertensive Emergencies and Severe Hypertension in Nonpregnant and Nonstroke Patients"
],
"chapter_id": "sec-10",
"sub... |
blood-pressure-2025_sec-10-2_scenario_q01 | A 50-year-old female with a known history of aortic dissection comes to the hospital with a blood pressure of 210/140 mm Hg. How should her blood pressure be managed in the first hour of treatment? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-2"
],
"title_path": [
"Complications of Management",
"Hypertensive Emergencies and Severe Hypertension in Nonpregnant and Nonstroke Patients"
],
"chapter_id": "sec-10",
"sub... |
blood-pressure-2025_sec-10-2_sdm_q01 | In discussing treatment options for a patient presenting with a hypertensive emergency, how should I explain the importance of immediate blood pressure reduction and the potential risks of aggressive treatment? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-2"
],
"title_path": [
"Complications of Management",
"Hypertensive Emergencies and Severe Hypertension in Nonpregnant and Nonstroke Patients"
],
"chapter_id": "sec-10",
"sub... |
blood-pressure-2025_sec-10-3_lookup_q01 | What are the common antihypertensive medications associated with erectile dysfunction in men, and which medication is noted for having the most favorable profile? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-3"
],
"title_path": [
"Complications of Management",
"Sexual Dysfunction"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-3",
"char_count": 1881
} |
blood-pressure-2025_sec-10-3_scenario_q01 | A 55-year-old man who has been on an ACE inhibitor for hypertension presents with erectile dysfunction. Considering the medication's profile, what are the next steps in managing his sexual health? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-3"
],
"title_path": [
"Complications of Management",
"Sexual Dysfunction"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-3",
"char_count": 1881
} |
blood-pressure-2025_sec-10-3_sdm_q01 | How can I effectively discuss the potential impacts of antihypertensive medications on my patient's sexual function to ensure they feel comfortable addressing any concerns? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-3"
],
"title_path": [
"Complications of Management",
"Sexual Dysfunction"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-3",
"char_count": 1881
} |
blood-pressure-2025_sec-10-4_lookup_q01 | What should be done regarding beta-blockers in patients with hypertension who are scheduled for major surgery and have been taking them chronically? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-4"
],
"title_path": [
"Complications of Management",
"Patients Scheduled for Surgical Procedures"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-4",
"char_count": 10094... |
blood-pressure-2025_sec-10-4_scenario_q01 | A 65-year-old woman with a history of hypertension is scheduled for elective hip replacement surgery. She has been stable on her current antihypertensive regimen. Should her medications be continued throughout the perioperative period? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-4"
],
"title_path": [
"Complications of Management",
"Patients Scheduled for Surgical Procedures"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-4",
"char_count": 10094... |
blood-pressure-2025_sec-10-4_sdm_q01 | How can I effectively communicate to a patient scheduled for major surgery the importance of continuing their beta-blocker therapy during the perioperative period for better blood pressure control? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-10-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-10",
"sec-10-4"
],
"title_path": [
"Complications of Management",
"Patients Scheduled for Surgical Procedures"
],
"chapter_id": "sec-10",
"subtopic_id": "sec-10-4",
"char_count": 10094... |
blood-pressure-2025_sec-6-1_lookup_q01 | How should blood pressure be categorized for adults to effectively prevent and treat high blood pressure according to the 2025 AHA guidelines? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-6-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-1"
],
"title_path": [
"Definitions and Classification of BP",
"Definition of High BP"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-1",
"char_count": 5610
} |
blood-pressure-2025_sec-6-1_scenario_q01 | A 62-year-old man with a history of obesity and diabetes presents with a blood pressure of 145/90 mmHg. What classification should be applied to his blood pressure based on the current recommendations? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-6-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-1"
],
"title_path": [
"Definitions and Classification of BP",
"Definition of High BP"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-1",
"char_count": 5610
} |
blood-pressure-2025_sec-6-1_sdm_q01 | How can I explain to my patient the importance of categorizing their blood pressure as normal, elevated, or hypertensive, and how this classification affects their treatment options? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-6-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-1"
],
"title_path": [
"Definitions and Classification of BP",
"Definition of High BP"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-1",
"char_count": 5610
} |
blood-pressure-2025_sec-7-1_lookup_q01 | What standardized methods are recommended for the accurate measurement and documentation of in-office blood pressure when diagnosing and managing high blood pressure in adults? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-7-1",
"level": 3,
"section_type": "container",
"path": [
"bodymatter",
"sec-7",
"sec-7-1"
],
"title_path": [
"Evaluation and Diagnosis",
"Patient Evaluation"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-1",
"char_count": 30417
} |
blood-pressure-2025_sec-7-1_scenario_q01 | A 47-year-old female patient with newly diagnosed hypertension reports feeling anxious during her office visits, leading to elevated blood pressure readings. What out-of-office blood pressure monitoring method is recommended to confirm her diagnosis? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-7-1",
"level": 3,
"section_type": "container",
"path": [
"bodymatter",
"sec-7",
"sec-7-1"
],
"title_path": [
"Evaluation and Diagnosis",
"Patient Evaluation"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-1",
"char_count": 30417
} |
blood-pressure-2025_sec-7-1_sdm_q01 | When discussing the importance of accurate blood pressure measurement with a patient who has recently been diagnosed with hypertension, how can I effectively explain the benefits of using standardized methods and the implications of inaccurate readings on their treatment plan? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-7-1",
"level": 3,
"section_type": "container",
"path": [
"bodymatter",
"sec-7",
"sec-7-1"
],
"title_path": [
"Evaluation and Diagnosis",
"Patient Evaluation"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-1",
"char_count": 30417
} |
blood-pressure-2025_sec-7-2_lookup_q01 | What is the recommended approach for adults with untreated office systolic blood pressure of 130 mm Hg or higher to exclude white-coat hypertension before making a diagnosis? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-7-2",
"level": 3,
"section_type": "container",
"path": [
"bodymatter",
"sec-7",
"sec-7-2"
],
"title_path": [
"Evaluation and Diagnosis",
"Patient Diagnosis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-2",
"char_count": 60690
} |
blood-pressure-2025_sec-7-2_scenario_q01 | A 62-year-old man with a history of resistant hypertension is currently on multiple antihypertensive medications. His office blood pressure is recorded at 150/95 mm Hg today. What does the guideline recommend regarding out-of-office blood pressure monitoring to exclude a white-coat effect? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-7-2",
"level": 3,
"section_type": "container",
"path": [
"bodymatter",
"sec-7",
"sec-7-2"
],
"title_path": [
"Evaluation and Diagnosis",
"Patient Diagnosis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-2",
"char_count": 60690
} |
blood-pressure-2025_sec-7-2_sdm_q01 | How can I effectively communicate the need for out-of-office blood pressure monitoring to a patient with suspected white-coat hypertension to help them understand its importance in confirming their diagnosis? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-7-2",
"level": 3,
"section_type": "container",
"path": [
"bodymatter",
"sec-7",
"sec-7-2"
],
"title_path": [
"Evaluation and Diagnosis",
"Patient Diagnosis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-2",
"char_count": 60690
} |
blood-pressure-2025_sec-8_lookup_q01 | What healthy lifestyle behaviors are recommended to prevent hypertension, particularly for those who may have a genetic predisposition? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-8",
"level": 2,
"section_type": "chapter",
"path": [
"bodymatter",
"sec-8"
],
"title_path": [
"Prevention Strategies"
],
"chapter_id": "sec-8",
"subtopic_id": "",
"char_count": 1096
} |
blood-pressure-2025_sec-8_scenario_q01 | What lifestyle changes should I recommend to a 45-year-old woman with a BMI of 29 who is concerned about developing high blood pressure? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-8",
"level": 2,
"section_type": "chapter",
"path": [
"bodymatter",
"sec-8"
],
"title_path": [
"Prevention Strategies"
],
"chapter_id": "sec-8",
"subtopic_id": "",
"char_count": 1096
} |
blood-pressure-2025_sec-8_sdm_q01 | How can I effectively discuss the importance of a heart-healthy diet and sodium intake with my patient who is concerned about making drastic dietary changes? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-8",
"level": 2,
"section_type": "chapter",
"path": [
"bodymatter",
"sec-8"
],
"title_path": [
"Prevention Strategies"
],
"chapter_id": "sec-8",
"subtopic_id": "",
"char_count": 1096
} |
blood-pressure-2025_sec-9-1_lookup_q01 | What weight loss goal is recommended for adults with overweight or obesity to prevent or treat elevated blood pressure and hypertension? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-1"
],
"title_path": [
"BP Management",
"Lifestyle and Psychosocial Approaches"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-1",
"char_count": 24210
} |
blood-pressure-2025_sec-9-1_scenario_q01 | A 38-year-old man with elevated blood pressure reports consuming two alcoholic drinks daily. What guidance does the guideline provide regarding alcohol consumption for someone in his situation? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-1"
],
"title_path": [
"BP Management",
"Lifestyle and Psychosocial Approaches"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-1",
"char_count": 24210
} |
blood-pressure-2025_sec-9-1_sdm_q01 | How can I effectively communicate the importance of weight loss to a 55-year-old male patient who is struggling with obesity and has elevated blood pressure, emphasizing the goal of at least 5% body weight reduction? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-1"
],
"title_path": [
"BP Management",
"Lifestyle and Psychosocial Approaches"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-1",
"char_count": 24210
} |
blood-pressure-2025_sec-9-2_lookup_q01 | What is the recommended threshold for initiating antihypertensive medication in adults with hypertension when their average systolic blood pressure is 140 mm Hg or greater? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-2"
],
"title_path": [
"BP Management",
"Medical Management"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-2",
"char_count": 100163
} |
blood-pressure-2025_sec-9-2_scenario_q01 | A 62-year-old woman with a history of diabetes presents with a blood pressure reading of 135/85 mm Hg. Given her risk factors, should we initiate antihypertensive medications for her? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-2"
],
"title_path": [
"BP Management",
"Medical Management"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-2",
"char_count": 100163
} |
blood-pressure-2025_sec-9-2_sdm_q01 | How can I explain to a patient with stage 1 hypertension and diabetes the importance of starting antihypertensive medication when their blood pressure is only slightly elevated? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-2"
],
"title_path": [
"BP Management",
"Medical Management"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-2",
"char_count": 100163
} |
blood-pressure-2025_sec-9-3_lookup_q01 | What is the recommended blood pressure treatment goal for adults with type 2 diabetes and hypertension, and at what systolic blood pressure should antihypertensive treatment be initiated? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-3"
],
"title_path": [
"BP Management",
"Comorbidities"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-3",
"char_count": 67891
} |
blood-pressure-2025_sec-9-3_scenario_q01 | A 72-year-old man with a history of hypertension and chronic kidney disease presents with an eGFR of 50 mL/min/1.73 m². What should be the target SBP for his hypertension management? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-3"
],
"title_path": [
"BP Management",
"Comorbidities"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-3",
"char_count": 67891
} |
blood-pressure-2025_sec-9-3_sdm_q01 | In managing a 65-year-old male patient with hypertension and chronic kidney disease, how should I explain the importance of controlling his blood pressure to prevent further kidney damage, and what specific treatment options can I discuss with him? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-3"
],
"title_path": [
"BP Management",
"Comorbidities"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-3",
"char_count": 67891
} |
blood-pressure-2025_sec-9-4_lookup_q01 | What is the recommended approach for managing adults with uncontrolled hypertension to achieve and maintain blood pressure control? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-4"
],
"title_path": [
"BP Management",
"Plan of Care for Hypertension"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-4",
"char_count": 23726
} |
blood-pressure-2025_sec-9-4_scenario_q01 | A 48-year-old woman with uncontrolled hypertension is currently on two antihypertensive medications but still has a blood pressure of 150/95 mm Hg. What steps should we take to assess her medication adherence and treatment response? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-4"
],
"title_path": [
"BP Management",
"Plan of Care for Hypertension"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-4",
"char_count": 23726
} |
blood-pressure-2025_sec-9-4_sdm_q01 | How can I effectively communicate the importance of a team-based care approach to my patient with uncontrolled hypertension, and what should I emphasize about the roles of different team members in their management? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-4"
],
"title_path": [
"BP Management",
"Plan of Care for Hypertension"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-4",
"char_count": 23726
} |
blood-pressure-2025_sec-9-5_lookup_q01 | What antihypertensive medications are preferred for individuals with hypertension who are planning a pregnancy or who become pregnant? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-5"
],
"title_path": [
"BP Management",
"Hypertension and Pregnancy"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-5",
"char_count": 23860
} |
blood-pressure-2025_sec-9-5_scenario_q01 | A 28-year-old female patient with chronic hypertension diagnosed before pregnancy is currently 18 weeks along. What blood pressure target should she aim for to prevent complications? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-5"
],
"title_path": [
"BP Management",
"Hypertension and Pregnancy"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-5",
"char_count": 23860
} |
blood-pressure-2025_sec-9-5_sdm_q01 | How can I effectively communicate the importance of using labetalol or extended-release nifedipine to a pregnant patient with hypertension, ensuring she understands the benefits to both her and her baby? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-5"
],
"title_path": [
"BP Management",
"Hypertension and Pregnancy"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-5",
"char_count": 23860
} |
blood-pressure-2025_sec-9-6_lookup_q01 | What evaluation is recommended for adults with resistant hypertension to identify secondary causes and simplify treatment? | lookup | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-6"
],
"title_path": [
"BP Management",
"Resistant Hypertension and Renal Denervation"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-6",
"char_count": 33941
} |
blood-pressure-2025_sec-9-6_scenario_q01 | A 55-year-old man presents with resistant hypertension, currently on three medications: an ARB, a CCB, and a thiazide-like diuretic. His eGFR is 50 mL/min. He has been adherent to his medications but continues to have an office BP of 150/95 mm Hg. What does the guideline suggest for managing his blood pressure? | scenario | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-6"
],
"title_path": [
"BP Management",
"Resistant Hypertension and Renal Denervation"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-6",
"char_count": 33941
} |
blood-pressure-2025_sec-9-6_sdm_q01 | How can I effectively communicate the need for a detailed evaluation of secondary causes in a patient with resistant hypertension who is hesitant about undergoing additional tests? | sdm | blood-pressure-2025 | 2025 AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults | {
"node_id": "sec-9-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-9",
"sec-9-6"
],
"title_path": [
"BP Management",
"Resistant Hypertension and Renal Denervation"
],
"chapter_id": "sec-9",
"subtopic_id": "sec-9-6",
"char_count": 33941
} |
cvd-prevention-2019_sec-5-1_lookup_q01 | What approach is recommended for managing risk factors associated with ASCVD in a team-based care setting? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-1"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Patient-Centered Approaches to Comprehensive ASCVD Prevention"
],
"chapter_id": "sec-5",
"sub... |
cvd-prevention-2019_sec-5-1_scenario_q01 | A 50-year-old man presents with a family history of cardiovascular disease and is looking for ways to lower his risk. According to the guidelines, how should shared decision-making be utilized in his care plan? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-1"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Patient-Centered Approaches to Comprehensive ASCVD Prevention"
],
"chapter_id": "sec-5",
"sub... |
cvd-prevention-2019_sec-5-1_sdm_q01 | How can I effectively communicate the importance of a team-based care approach to a patient who is hesitant about involving multiple healthcare providers in their ASCVD risk management? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-1"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Patient-Centered Approaches to Comprehensive ASCVD Prevention"
],
"chapter_id": "sec-5",
"sub... |
cvd-prevention-2019_sec-5-2_lookup_q01 | What key elements do the 2019 ACC/AHA guidelines emphasize for effective ASCVD prevention efforts in clinical practice? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-2"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Synopsis"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-2",
"char_count": 515
} |
cvd-prevention-2019_sec-5-2_scenario_q01 | A 62-year-old woman with a history of hypertension and hyperlipidemia comes to the clinic for a routine check-up. She is currently taking lisinopril and atorvastatin. What recommendations should we consider for her regarding the prevention of cardiovascular disease? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-2"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Synopsis"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-2",
"char_count": 515
} |
cvd-prevention-2019_sec-5-2_sdm_q01 | How can I effectively communicate the importance of team-based care and shared decision-making in preventing atherosclerotic cardiovascular disease (ASCVD) to my patient? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-2",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-2"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Synopsis"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-2",
"char_count": 515
} |
cvd-prevention-2019_sec-5-3_lookup_q01 | What types of approaches have demonstrated greater reductions in ASCVD risk compared to usual care in patients with hypertension, diabetes, and hyperlipidemia? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-3"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-3",
... |
cvd-prevention-2019_sec-5-3_scenario_q01 | A 45-year-old man recently diagnosed with type 2 diabetes is anxious about managing his cardiovascular risk. How can we involve him in shared decision-making regarding lifestyle changes and potential medical therapies for ASCVD prevention? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-3"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-3",
... |
cvd-prevention-2019_sec-5-3_sdm_q01 | How can I effectively communicate the importance of team-based care in managing my patient's ASCVD risk, particularly for those with diabetes and hypertension? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-3"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-3",
... |
cvd-prevention-2019_sec-5-5_lookup_q01 | What should be considered when estimating the 10-year ASCVD risk for individual patients to guide preventive interventions? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-5"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Synopsis"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-5",
"char_count": 2009
} |
cvd-prevention-2019_sec-5-5_scenario_q01 | A 39-year-old woman with a family history of premature coronary artery disease and high cholesterol levels is seeking advice on lifestyle changes. What should we do to assess her ASCVD risk and discuss both lifestyle and potential pharmacotherapy? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-5"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Synopsis"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-5",
"char_count": 2009
} |
cvd-prevention-2019_sec-5-5_sdm_q01 | How can I effectively communicate the importance of a 10-year ASCVD risk assessment to my patient before discussing preventive treatment options? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-5"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Synopsis"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-5",
"char_count": 2009
} |
cvd-prevention-2019_sec-5-6_lookup_q01 | What screening method is recommended to estimate 10-year ASCVD risk for asymptomatic adults aged 40 to 75? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-6"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-6",
... |
cvd-prevention-2019_sec-5-6_scenario_q01 | A 39-year-old white female with a history of gestational diabetes has a blood pressure of 138/88 mm Hg. Her 10-year ASCVD risk is estimated at 9%. What lifestyle interventions should be recommended? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-6"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-6",
... |
cvd-prevention-2019_sec-5-6_sdm_q01 | How can I effectively communicate the importance of evaluating a patient's 10-year ASCVD risk when discussing lifestyle changes and potential medication for someone with stage 1 hypertension? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-5-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-5",
"sec-5-6"
],
"title_path": [
"Overarching Recommendations for ASCVD Prevention Efforts",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-5",
"subtopic_id": "sec-5-6",
... |
cvd-prevention-2019_sec-6-1_lookup_q01 | What dietary changes are recommended to lower the risk factors associated with atherosclerotic cardiovascular disease? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-1"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Nutrition and Diet"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-1",
"char_count": 2619
} |
cvd-prevention-2019_sec-6-1_scenario_q01 | A 67-year-old man who has been advised to improve his heart health is interested in what processed foods he should limit in his diet. What recommendations should he follow to minimize his cardiovascular risk? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-1"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Nutrition and Diet"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-1",
"char_count": 2619
} |
cvd-prevention-2019_sec-6-1_sdm_q01 | How can I effectively discuss the importance of a diet rich in vegetables, fruits, and whole grains with a patient who is hesitant to change their eating habits? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-1"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Nutrition and Diet"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-1",
"char_count": 2619
} |
cvd-prevention-2019_sec-6-3_lookup_q01 | What dietary patterns are associated with lower all-cause mortality according to the 2019 ACC/AHA guidelines? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-3"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-3",
"char_c... |
cvd-prevention-2019_sec-6-3_scenario_q01 | A 65-year-old woman with hypertension and a BMI of 30 is looking to improve her diet to reduce her cardiovascular risk. What dietary changes should she consider to align with the recommended guidelines? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-3"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-3",
"char_c... |
cvd-prevention-2019_sec-6-3_sdm_q01 | How can I effectively communicate the benefits of a Mediterranean diet to a 55-year-old male patient with high blood pressure who is skeptical about changing his eating habits? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-3"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-3",
"char_c... |
cvd-prevention-2019_sec-6-4_lookup_q01 | What is the recommended amount of aerobic physical activity for adults to reduce their risk of atherosclerotic cardiovascular disease? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-4"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Exercise and Physical Activity"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-4",
"char_count": 24... |
cvd-prevention-2019_sec-6-4_scenario_q01 | For a 45-year-old man who currently exercises only 30 minutes a week, what is the guideline recommendation for the amount of aerobic physical activity he should aim for to lower his ASCVD risk? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-4"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Exercise and Physical Activity"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-4",
"char_count": 24... |
cvd-prevention-2019_sec-6-4_sdm_q01 | How can I effectively counsel a 65-year-old patient who is hesitant to increase their physical activity levels due to concerns about injury, while emphasizing the importance of at least 150 minutes of moderate-intensity exercise per week? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-4"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Exercise and Physical Activity"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-4",
"char_count": 24... |
cvd-prevention-2019_sec-6-5_lookup_q01 | What are the recommended strategies to increase physical activity among adults who do not meet the minimum recommendations for cardiovascular health? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-5"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-5",
"char_count": 1708
} |
cvd-prevention-2019_sec-6-5_scenario_q01 | What exercise recommendations should I provide to a 65-year-old woman who has been sedentary but wants to improve her cardiovascular health? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-5"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-5",
"char_count": 1708
} |
cvd-prevention-2019_sec-6-5_sdm_q01 | How can I encourage a sedentary patient to start an exercise program while addressing their concerns about safety and intensity? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-5",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-5"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-5",
"char_count": 1708
} |
cvd-prevention-2019_sec-6-6_lookup_q01 | What is the minimum recommended amount of moderate-intensity aerobic physical activity for all adults to lower the risk of atherosclerotic cardiovascular disease (ASCVD) according to the 2019 ACC/AHA guidelines? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-6"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-6",
"char_c... |
cvd-prevention-2019_sec-6-6_scenario_q01 | A 45-year-old man is currently active for about 60 minutes a week, mostly walking slowly and doing light housework. He wants to improve his cardiovascular health. What amount and type of physical activity should I encourage him to achieve? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-6"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-6",
"char_c... |
cvd-prevention-2019_sec-6-6_sdm_q01 | How can I effectively counsel a patient who is currently sedentary and resistant to increasing their physical activity levels, especially regarding the benefits of even small amounts of moderate-to-vigorous exercise? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-6-6",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-6",
"sec-6-6"
],
"title_path": [
"Lifestyle Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-6",
"subtopic_id": "sec-6-6",
"char_c... |
cvd-prevention-2019_sec-7-10_lookup_q01 | What nonpharmacological interventions are recommended for adults with elevated blood pressure or hypertension to help reduce their blood pressure? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-10",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-10"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With High Blood Pressure or Hypertension"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-10",
... |
cvd-prevention-2019_sec-7-10_scenario_q01 | For a 50-year-old man with confirmed hypertension and a history of chronic kidney disease, what should be the target blood pressure according to the guidelines? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-10",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-10"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With High Blood Pressure or Hypertension"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-10",
... |
cvd-prevention-2019_sec-7-10_sdm_q01 | How can I effectively discuss nonpharmacological interventions for managing hypertension with a patient who is hesitant to change their lifestyle? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-10",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-10"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With High Blood Pressure or Hypertension"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-10",
... |
cvd-prevention-2019_sec-7-11_lookup_q01 | What are the recommended actions for individuals with elevated blood pressure defined as 120–129/<80 mm Hg according to the 2019 ACC/AHA guidelines? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-11",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-11"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-11",
"char_count": 4369
} |
cvd-prevention-2019_sec-7-11_scenario_q01 | A 66-year-old woman presents with a blood pressure of 130/85 mm Hg and no significant history of cardiovascular disease. What should be the management strategy according to current recommendations? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-11",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-11"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-11",
"char_count": 4369
} |
cvd-prevention-2019_sec-7-11_sdm_q01 | How can I effectively communicate the importance of managing elevated blood pressure to a 55-year-old male patient who has been noncompliant with lifestyle changes and is hesitant about starting medication? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-11",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-11"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-11",
"char_count": 4369
} |
cvd-prevention-2019_sec-7-13_lookup_q01 | What should be assessed at every healthcare visit for all adults regarding tobacco use? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-13",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-13"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Treatment of Tobacco Use"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-13",
"char_count": 2521
} |
cvd-prevention-2019_sec-7-13_scenario_q01 | A 38-year-old man is a heavy smoker and has recently been diagnosed with hypertension. What is the recommended approach for managing his tobacco use in relation to his cardiovascular risk? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-13",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-13"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Treatment of Tobacco Use"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-13",
"char_count": 2521
} |
cvd-prevention-2019_sec-7-13_sdm_q01 | How can I effectively communicate the importance of assessing tobacco use during every healthcare visit to a patient who may not see it as a priority? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-13",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-13"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Treatment of Tobacco Use"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-13",
"char_count": 2521
} |
cvd-prevention-2019_sec-7-14_lookup_q01 | What does the 2019 ACC/AHA guideline recommend regarding tobacco cessation treatment in clinical settings for all tobacco users? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-14",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-14"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-14",
"char_count": 1215
} |
cvd-prevention-2019_sec-7-14_scenario_q01 | A 38-year-old woman who has never smoked but is frequently exposed to secondhand smoke at home is concerned about her risk for cardiovascular disease. What does the guideline recommend regarding her exposure and its implications for her health? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-14",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-14"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-14",
"char_count": 1215
} |
cvd-prevention-2019_sec-7-14_sdm_q01 | How can I effectively communicate to my patient the risks associated with smoking and the benefits of cessation, especially if they express doubt about the severity of their tobacco use? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-14",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-14"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-14",
"char_count": 1215
} |
cvd-prevention-2019_sec-7-15_lookup_q01 | What are the recommended screening questions for assessing tobacco use status in adults during healthcare visits? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-15",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-15"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-15",
"char_co... |
cvd-prevention-2019_sec-7-15_scenario_q01 | For a 60-year-old man who has recently been diagnosed with hypertension and is a former smoker, how should we approach his tobacco use history during his follow-up visit? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-15",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-15"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-15",
"char_co... |
cvd-prevention-2019_sec-7-15_sdm_q01 | How can I effectively communicate the importance of discussing tobacco use with my patients, especially those who may not initially disclose their smoking status? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-15",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-15"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-15",
"char_co... |
cvd-prevention-2019_sec-7-17_lookup_q01 | What are the considerations regarding aspirin use for primary prevention of ASCVD in patients without prior history of the disease? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-17",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-17"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-17",
"char_count": 1382
} |
cvd-prevention-2019_sec-7-17_scenario_q01 | A 62-year-old woman with hypertension and hyperlipidemia has no prior history of cardiovascular disease. Should she be started on aspirin for primary prevention? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-17",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-17"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-17",
"char_count": 1382
} |
cvd-prevention-2019_sec-7-17_sdm_q01 | How can I effectively communicate the risks and benefits of aspirin for primary prevention of cardiovascular disease to my patient who has no prior history of ASCVD? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-17",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-17"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Synopsis"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-17",
"char_count": 1382
} |
cvd-prevention-2019_sec-7-18_lookup_q01 | What is the recommended approach to prophylactic aspirin use for adults aged 40 to 70 years regarding their ASCVD risk and bleeding risk factors? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-18",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-18"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-18",
"char_co... |
cvd-prevention-2019_sec-7-18_scenario_q01 | A 58-year-old man with type 2 diabetes and an estimated 12% 10-year ASCVD risk is asking about starting low-dose aspirin for primary prevention. Given his risk factors, what should be considered according to the guideline? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-18",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-18"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-18",
"char_co... |
cvd-prevention-2019_sec-7-18_sdm_q01 | How can I effectively communicate the potential benefits and risks of starting low-dose aspirin for primary prevention to a 65-year-old male patient with a family history of premature heart disease? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-18",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-18"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-18",
"char_co... |
cvd-prevention-2019_sec-7-1_lookup_q01 | What is recommended for individuals with overweight and obesity to improve their ASCVD risk factor profile? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-1"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With Overweight and Obesity"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-1",
"char_count": 22... |
cvd-prevention-2019_sec-7-1_scenario_q01 | A 45-year-old woman with a BMI of 32 presents for a routine check-up. What recommendations should I follow to help her improve her cardiovascular risk profile? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-1"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With Overweight and Obesity"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-1",
"char_count": 22... |
cvd-prevention-2019_sec-7-1_sdm_q01 | How can I effectively communicate the importance of weight loss to a 55-year-old male patient with obesity, considering his concerns about making lifestyle changes? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-1",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-1"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With Overweight and Obesity"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-1",
"char_count": 22... |
cvd-prevention-2019_sec-7-3_lookup_q01 | What is the recommended amount of physical activity for adults with obesity to achieve initial weight loss according to the guideline? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-3"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-3",
"char_count... |
cvd-prevention-2019_sec-7-3_scenario_q01 | For a 60-year-old man with a waist circumference of 42 inches and a BMI of 29, what interventions should I consider to address his increased cardiometabolic risk? | scenario | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-3"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-3",
"char_count... |
cvd-prevention-2019_sec-7-3_sdm_q01 | How can I effectively communicate the importance of weight loss to a patient with obesity who is hesitant to start a comprehensive lifestyle intervention, emphasizing the benefits on blood pressure and glucose levels? | sdm | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-3",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-3"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Recommendation-Specific Supportive Text"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-3",
"char_count... |
cvd-prevention-2019_sec-7-4_lookup_q01 | What dietary recommendations are made for adults with type 2 diabetes mellitus to improve glycemic control and cardiovascular health? | lookup | cvd-prevention-2019 | 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease | {
"node_id": "sec-7-4",
"level": 3,
"section_type": "subsection",
"path": [
"bodymatter",
"sec-7",
"sec-7-4"
],
"title_path": [
"Other Factors Affecting Cardiovascular Risk",
"Adults With Type 2 Diabetes Mellitus"
],
"chapter_id": "sec-7",
"subtopic_id": "sec-7-4",
"char_count": ... |
End of preview. Expand in Data Studio
Synthetic clinical question set for verbatim-citation evaluation
222 synthetic clinical questions, each written from one section of a published cardiometabolic practice guideline.
Questions carry the identifier of their source section, not its text. The guidelines are copyrighted and cannot be redistributed, so you need your own copy of them. The harness rebuilds the section tree from them, and the labels resolve against that tree.
Paper: arXiv:2609.15964 Code and harness: github.com/oberst-lab/verifiable-by-construction
Fields
| Field | Notes |
|---|---|
question_id |
unique, shaped <guideline_id>_<node_id>_<style>_qNN |
question |
the question text |
question_style |
lookup (asks for a recommendation directly), scenario (describes one patient and asks what applies to them), or sdm (asks how to discuss the options with a patient). 74 each |
guideline_id |
blood-pressure-2025 (42), cvd-prevention-2019 (75), diabetes-care-2026 (75), dyslipidemia-2026 (30) |
guideline_name |
the guideline's full title |
source |
the gold label: which section the question came from |
Inside source:
| Key | Notes |
|---|---|
node_id |
the gold section. Unique only together with guideline_id, since section ids repeat across guidelines |
chapter_id, subtopic_id |
the same section at chapter and at subtopic granularity |
path |
node ids from the document root down to the section |
title_path |
the corresponding section headings |
level, section_type |
position in the section tree |
char_count |
length of the section text |
74 sections in total, three questions on each. Generated with gpt-4o-mini, one
section at a time.
License
CC BY 4.0 covers the questions and labels here. The guidelines themselves belong to the bodies that issued them.
Citation
Jiashuo Zhang, Yuling Chen, Yvonne Commodore-Mensah, Michael Oberst. Verifiable by Construction: Claim-Level Evaluation of Verbatim Citation in Clinical Question Answering. arXiv:2609.15964, 2026.
- Downloads last month
- 17